Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a new Revision: v3.6.3 entry to the study record history, replacing the previous v3.6.2. This reflects a system update to the page rather than a modification to the study data or visible content.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.6.2 is now displayed in the page footer, replacing v3.6.0. This reflects a software release or patch applied to the site and does not modify study data or visible content beyond the version label.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded a note that the study is no longer looking for participants, updating the recruitment status in the history. The revision tag was updated to v3.6.0, replacing the previous v3.5.5 in the history.SummaryDifference0.2%

- Check44 days agoChange DetectedThe record history now shows a new revision entry labeled v3.5.5, replacing the previous v3.5.4. This reflects an administrative update to the page's revision history rather than changes to the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedA References section was added to the study record history, introducing source citations for the study's details. This helps users verify and follow the sources for the information presented.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the study's Record History, representing the latest version of the record.SummaryDifference0.1%

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.